G enetic deletion of x CT attenuates peripheral and central inflammation and mitigates LPS ‐induced sickness and depressive‐like behavior in mice

Abstract The communication between the immune and central nervous system (CNS) is affected in many neurological disorders. Peripheral injections of the endotoxin lipopolysaccharide (LPS) are widely used to study this communication: an LPS challenge leads to a biphasic syndrome that starts with acute...

Full description

Saved in:
Bibliographic Details
Published in:Glia 2018-09, Vol.66 (9), p.1845-1861
Main Authors: Albertini, Giulia, Deneyer, Lauren, Ottestad‐Hansen, Sigrid, Zhou, Yun, Ates, Gamze, Walrave, Laura, Demuyser, Thomas, Bentea, Eduard, Sato, Hideyo, De Bundel, Dimitri, Danbolt, Niels C., Massie, Ann, Smolders, Ilse
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The communication between the immune and central nervous system (CNS) is affected in many neurological disorders. Peripheral injections of the endotoxin lipopolysaccharide (LPS) are widely used to study this communication: an LPS challenge leads to a biphasic syndrome that starts with acute sickness and is followed by persistent brain inflammation and chronic behavioral alterations such as depressive‐like symptoms. In vitro , the response to LPS treatment has been shown to involve enhanced expression of system . This cystine‐glutamate antiporter, with xCT as specific subunit, represents the main glial provider of extracellular glutamate in mouse hippocampus. Here we injected male xCT knockout and wildtype mice with a single intraperitoneal dose of 5 mg/kg LPS. LPS‐injection increased hippocampal xCT expression but did not alter the mainly astroglial localization of the xCT protein. Peripheral and central inflammation (as defined by cytokine levels and morphological activation of microglia) as well as LPS‐induced sickness and depressive‐like behavior were significantly attenuated in xCT‐deficient mice compared with wildtype mice. Our study is the first to demonstrate the involvement of system in peripheral and central inflammation in vivo and the potential therapeutic relevance of its inhibition in brain disorders characterized by peripheral and central inflammation, such as depression.
ISSN:0894-1491
1098-1136
DOI:10.1002/glia.23343